GlobeNewswire: Vascular Solutions, Inc. Contains the last 10 of 172 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T00:23:35ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2017/02/16/918163/0/en/Vascular-Solutions-Shareholders-Approve-Acquisition-by-Teleflex.html?f=22&fvtc=4&fvtv=6337Vascular Solutions Shareholders Approve Acquisition by Teleflex2017-02-16T15:29:25Z<![CDATA[MINNEAPOLIS, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced that at the Special Meeting of Shareholders held earlier today, Vascular Solutions shareholders voted to approve the company’s proposed acquisition by Teleflex Incorporated (NYSE:TFX).]]>https://www.globenewswire.com/news-release/2016/12/02/894630/0/en/Vascular-Solutions-to-be-Acquired-by-Teleflex-Incorporated.html?f=22&fvtc=4&fvtv=6337Vascular Solutions to be Acquired by Teleflex Incorporated2016-12-02T11:46:00Z<![CDATA[MINNEAPOLIS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has entered into a definitive agreement to be acquired by Teleflex Incorporated (NYSE:TFX) for a purchase price of $56.00 per share in cash. The transaction implies an equity purchase price of $1.0 billion. Upon completion of the transaction, Vascular Solutions will become a wholly owned subsidiary of Teleflex.]]>https://www.globenewswire.com/news-release/2016/10/27/883880/0/en/Vascular-Solutions-to-Present-at-Upcoming-Investor-Conferences.html?f=22&fvtc=4&fvtv=6337Vascular Solutions to Present at Upcoming Investor Conferences 2016-10-27T20:05:00Z<![CDATA[MINNEAPOLIS, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the company is scheduled to present at the Stifel 2016 Healthcare Conference  in New York City on Wednesday, November 16th at 11:00am (EST).  The company will also present at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York City on Thursday, November 17th at 11:00am (EST). ]]>https://www.globenewswire.com/news-release/2016/10/24/882207/0/en/Vascular-Solutions-Reports-Third-Quarter-Results.html?f=22&fvtc=4&fvtv=6337Vascular Solutions Reports Third Quarter Results2016-10-24T20:05:00Z<![CDATA[MINNEAPOLIS, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today reported financial results for the third quarter ended September 30, 2016.]]>https://www.globenewswire.com/news-release/2016/10/21/881638/0/en/Vascular-Solutions-Receives-510-k-Clearance-for-Fluent-Inflation-Device.html?f=22&fvtc=4&fvtv=6337Vascular Solutions Receives 510(k) Clearance for Fluent™ Inflation Device2016-10-21T12:30:00Z<![CDATA[MINNEAPOLIS, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Fluent inflation device for use during cardiovascular procedures to create, maintain, and monitor pressure in balloon catheters. Fluent received CE Mark clearance in August 2016 and has already begun international clinical evaluations. Vascular Solutions expects to commence the commercial launch of Fluent in the U.S. and Europe during the fourth quarter.]]>https://www.globenewswire.com/news-release/2016/10/18/880314/0/en/Vascular-Solutions-Announces-IND-Submission-for-RePlas-Freeze-Dried-Plasma.html?f=22&fvtc=4&fvtv=6337Vascular Solutions Announces IND Submission for RePlas™ Freeze-Dried Plasma2016-10-18T11:30:00Z<![CDATA[MINNEAPOLIS, Oct. 18, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for RePlas, a freeze-dried plasma product being developed in collaboration with the U.S. Army Medical Materiel Development Activity (USAMMDA).]]>https://www.globenewswire.com/news-release/2016/10/05/877380/0/en/VASCULAR-SOLUTIONS-ANNOUNCES-Q3-EARNINGS-DATE.html?f=22&fvtc=4&fvtv=6337VASCULAR SOLUTIONS ANNOUNCES Q3 EARNINGS DATE2016-10-05T20:05:00Z<![CDATA[MINNEAPOLIS, Minnesota , Oct. 05, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC) today announced that it will host a live webcast of its third quarter conference call on Monday, October 24, 2016 at 3:30pm CDT. Vascular Solutions’ Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company’s third quarter results. The company will issue an earnings news release after market close on Monday, October 24, 2016.]]>https://www.globenewswire.com/news-release/2016/10/04/877040/0/en/Vascular-Solutions-Inc-Issues-Recall-of-Twin-Pass-Dual-Access-Catheters.html?f=22&fvtc=4&fvtv=6337Vascular Solutions, Inc. Issues Recall of Twin-Pass® Dual Access Catheters2016-10-04T20:05:00Z<![CDATA[MINNEAPOLIS, Oct. 04, 2016 (GLOBE NEWSWIRE) -- On September 16, 2016, Vascular Solutions, Inc. (Nasdaq:VASC), initiated a nationwide recall of Twin-Pass Dual Access catheters used in catheterization procedures.  All unexpired lots of the product have been recalled because there is a potential for excess manufacturing material to remain at the tip of the catheter or within the distal portion of the rapid exchange lumen.  It is possible that the excess material may separate from the catheter during use and pose a potential risk of embolism, which could result in serious injury or death.  No injuries have been reported in association with this issue to date.]]>https://www.globenewswire.com/news-release/2016/09/13/871460/0/en/Vascular-Solutions-Surpasses-150-000-Successfully-Reprocessed-ClosureFAST-Catheters.html?f=22&fvtc=4&fvtv=6337Vascular Solutions Surpasses 150,000 Successfully Reprocessed ClosureFAST® Catheters2016-09-13T12:00:00Z<![CDATA[MINNEAPOLIS, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that more than 150,000 ClosureFAST catheters have been successfully reprocessed by its partner, Northeast Scientific, Inc. (NES), since Vascular Solutions launched the reprocessing service for the popular vein ablation catheters in January of 2012.]]>https://www.globenewswire.com/news-release/2016/07/27/859426/0/en/Vascular-Solutions-to-Present-at-the-Canaccord-Genuity-Growth-Conference.html?f=22&fvtc=4&fvtv=6337Vascular Solutions to Present at the Canaccord Genuity Growth Conference2016-07-27T20:05:00Z<![CDATA[MINNEAPOLIS, July 27, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Canaccord Genuity Growth Conference in Boston on Wednesday, August 10th at 8:00am (EDT). ]]>